Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 56
Healthy volunteers: yes

Brief summary:
The primary objective of this trial is to investigate the bioequivalence of one fixed dose combination tablet of empagliflozin/linagliptin (Test, T) compared with the free combination of one empagliflozin tablet and one linagliptin tablet (Reference, R) administered as single dose under fasted conditions.

Detailed description:

Arms:
arm 1: One tablet fix dose combination (FDC) arm 2: None

Interventions: intervention 1: Empagliflozin intervention 2: Linagliptin
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: